Evidence map›Paper›PMID 41366989›Full record

ReviewMedicine2025

Monocytes and immune evasion strategies in HIV: Unraveling the intricacies.

Emmanuel Ifeanyi Obeagu, Getrude Uzoma Obeagu

Abstract readReview
In one paragraph

Review in Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Emmanuel Ifeanyi ObeaguDepartment of Biomedical and Laboratory Science, Africa University, Mutare, Zimbabwe.ORCID 0000-0002-4538-0161
Getrude Uzoma ObeaguSchool of Nursing Science, Kampala International University, Ishaka, Uganda.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human immunodeficiency virus (HIV) employs sophisticated immune evasion strategies to establish persistent infection within the host. Monocytes, crucial components of the innate immune system, play a pivotal role in shaping the immune response against HIV. This review delves into the intricate interplay between monocytes and HIV, focusing on the virus's strategies to evade immune surveillance and the implications for disease progression. The phenotypic diversity of monocyte subsets, including classical, intermediate, and non-classical monocytes, adds complexity to their roles in HIV pathogenesis. The virus exploits monocytes as both targets for infection and reservoirs, impacting viral dissemination and persistence. Understanding the mechanisms of monocyte-HIV interactions is crucial for unraveling the dynamics of immune evasion. HIV employs various immune evasion strategies that directly manipulate monocyte functions. These include viral entry mechanisms that exploit monocyte receptors, modulation of monocyte cytokine responses, and interference with antigen presentation. The virus also shapes the monocyte phenotype to establish a pro-inflammatory environment that fosters viral replication while evading immune detection.

Indexed as

HIV InfectionsImmune EvasionMonocytesHumansImmunity, InnateVirus Replicationchronic immune activationHIVimmune evasionimmune modulationmonocytestherapeutic strategiesviral reservoirs

Identifiers

PMID41366989
PMCPMC12688896

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.